Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Sara Varnado"'
Publikováno v:
Methodist DeBakey cardiovascular journal. 18(5)
Heart failure with preserved ejection fraction (HFpEF) is a challenging disease state that has long been plagued by heterogeneity in diagnostic criteria and underlying etiologies. Due in part to the complexity of defining this disease and the simplis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a693fc0fbb115f9114c034729162aaca
https://pubmed.ncbi.nlm.nih.gov/36561091
https://pubmed.ncbi.nlm.nih.gov/36561091
Autor:
Annette Lista, Celia Morton, Emily A. Highsmith, Kevin R. Donahue, Sara Varnado, Suraj Sulhan
Publikováno v:
The Journal of Clinical Pharmacology. 61:598-605
Compared with vitamin K antagonists (VKAs), oral factor Xa inhibitors are associated with at least equivalent efficacy and a lower incidence of major bleeding. Despite this benefit, bleeding remains the most common adverse event. Prior to the approva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f83ac1741d03e7e3f921378828630f3a
https://doi.org/10.1002/jcph.1779
https://doi.org/10.1002/jcph.1779
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 40:169-173
Background Impella devices are being increasingly used to manage cardiogenic shock. The incidence of thrombosis and hemolysis in patients on Impella support increases with longer durations of use, and the management of Impella thrombosis remains ill-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d9014f9a4c848517446ef5f3255337
https://doi.org/10.1002/phar.2356
https://doi.org/10.1002/phar.2356
Autor:
Arvind Bhimaraj, Wadi N. Suki, Joshua T. Swan, Tomona Iso, Barry H. Trachtenberg, Elsie Rizk, Jill Krisl, Erik E. Suarez, Mahwash Kassi, Adaani E. Frost, Noel Martin Giesecke, Sara Varnado, Faisal Masud, Faisal S Uddin
Publikováno v:
ASAIO Journal.
This study aimed to develop a definition of vasoplegia that reliably predicts clinical outcomes. Vasoplegia was evaluated using data from the electronic health record for each 15-minute interval for 72 hours following cardiopulmonary bypass. Standard
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf5765b29ded8461e02846822d63020
https://doi.org/10.1097/mat.0000000000001419
https://doi.org/10.1097/mat.0000000000001419
Publikováno v:
Journal of clinical pharmacologyReferences. 61(1)
The primary objective of this study was to describe the impact on bleeding rates of 2 different strategies for transitioning from a direct oral anticoagulant (DOAC) to a parenteral anticoagulant: a delayed, clinically driven strategy versus the stand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::016ea01bf46ef9bd84857d3a74ebb424
https://pubmed.ncbi.nlm.nih.gov/32639606
https://pubmed.ncbi.nlm.nih.gov/32639606
Autor:
Sajni Patel, Libby A Orzel, Aaron Bagnola, Sara Zoubek, Pamela Simone, Michael Militello, Tracy Macaulay, Joshua A. Jacobs, Hasan Kazmi, Daniel Galipeau, Sara Varnado, J Michael Boyd, Anthony T Gerlach, John Lindsley, Brooke Gengler, Charles Hayes, Kerry K. Pickworth, Robert Barcelona, Rachel I. Lavelle, Heidi Brink, Maya R. Chilbert, Danielle Blais, Kristen Tasca
Publikováno v:
Journal of the American College of Clinical Pharmacy
Introduction The recent coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) challenges pharmacists worldwide. Alongside other specialized pharmacists, we re‐evaluated daily proce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9578e80d3da00277031d5c0ea60bc3
https://pubmed.ncbi.nlm.nih.gov/32838223
https://pubmed.ncbi.nlm.nih.gov/32838223
Publikováno v:
ASAIO Journal. 64:433-439
Left ventricular assist devices (LVADs) offer a therapeutic strategy for patients with end-stage heart failure. Increased device utilization has also increased the incidence of device-related complications including gastrointestinal bleeding (GIB). M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468b02a4824a56d73ad1c35e741ab134
https://doi.org/10.1097/mat.0000000000000758
https://doi.org/10.1097/mat.0000000000000758
Publikováno v:
Current Pharmaceutical Design. 22:1918-1932
Antiplatelet drugs are the cornerstone of therapy in many cardiovascular conditions. With the current success and increased use of transcatheter aortic valve implantation (TAVI), the use of antiplatelet therapy is considered part of the medical thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db665d89e76d8e88c0b8489afdd3c46
https://doi.org/10.2174/1381612822666151208120106
https://doi.org/10.2174/1381612822666151208120106
Autor:
Aleem Siddique, Brian D. Lowes, Eugenia Raichlin, John Y. Um, Michael J. Moulton, HelenMari Merritt-Genore, Ronald Zolty, J.L. Balk, H. Vongooru, Adam Burdorf, Timothy Ryan, Sara Varnado
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S373-S374
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::047f062edfaa0d987d237e90a0a46c00
https://doi.org/10.1016/j.healun.2016.01.1076
https://doi.org/10.1016/j.healun.2016.01.1076
Autor:
M.C. Zimmerman, Ronald Zolty, H. Vongooru, Eugenia Raichlin, Adam Burdorf, Sara Varnado, Marshall Hyden
Publikováno v:
The Journal of Heart and Lung Transplantation. 35:S388-S389
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1301b93aaba9fa830e1baf89e34c73f
https://doi.org/10.1016/j.healun.2016.01.1120
https://doi.org/10.1016/j.healun.2016.01.1120